Blood administration is not without risk.  Antifibrinolytic agents are used to control bleeding and blood product administration.  In particular, aprotinin has been shown to have adverse effects.  In one study comparing aprotinin to tranexamic acid or aminocaproic acid in patients undergoing high-risk cardiac surgery, the trial was ended early because of a high death(…)